XenoPort Financial Statements
XenoPort Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
XenoPort Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 113.8 | 10.6 | 4.8 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | 20.8 | (69.7) | (44.9) |
| Total Net Income ($ mil.) | 28.2 | (64.3) | (42.9) |
| Diluted EPS (Net Income) | 1.08 | (2.91) | (3.69) |
XenoPort Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 11.5 | 15.0 | 25.8 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (13.4) | (9.1) | 0.3 |
| Total Net Income ($ mil.) | (12.4) | (7.3) | 2.5 |
| Diluted EPS (Net Income) | (0.50) | (0.29) | 0.08 |
XenoPort Stock Quote & Chart
09/05/08 08:46:59 EST •
NASDAQ •
47.86
•
 -0.0300
•
-0.0626 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
XenoPort Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 13.96 | 3.75 | 1.56 |
| Price/Earnings Ratio | -- | 16.34 | 15.82 |
| Price/Book Ratio | 10.70 | 2.92 | 1.52 |
| Price/Cash Flow Ratio | -- | 13.17 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed XenoPort Financial Ratios
XenoPort Competitive Intelligence
| Abbott Labs | AstraZeneca | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 25,914.2 | -- | 48,418.0 |
| Employees | 68,000 | -- | 86,600 |
| Market Cap ($ mil.) | 90,488.8 | -- | 133,815.6 |
Competitive Landscape
